These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28362720)

  • 1. Diagnostic Value of Semiquantitative Analysis of 99mTechnetium-Methoxyisobutylisonitrile (99mTc-MIBI) Imaging in Predicting Early-Stage Cervical Lymph Node Metastasis of Thyroid Carcinoma.
    Zhu XC; Zhou K; Xu SQ; Ma YB
    Med Sci Monit; 2017 Mar; 23():1552-1558. PubMed ID: 28362720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Detection of Multidrug-Resistance Related Proteins in Locally Advanced Breast Cancer Using 99mTc-MIBI SPECT/CT Imaging: Correlation with Clinical Outcomes.
    Mostafa NM; Elnaggar MS; Abdelhafez YG; Rezk K; Sherif MF; Eltyb HA; Ahmed S; Abu Elnga NE; Hussien MT
    Asian Pac J Cancer Prev; 2024 Sep; 25(9):3125-3141. PubMed ID: 39342592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-operative prediction of cervical nodal metastasis in papillary thyroid cancer by 99mTc-MIBI SPECT/CT; a pilot study.
    Tangjaturonrasme N; Vasavid P; Sombuntham P; Keelawat S
    J Med Assoc Thai; 2013 Jun; 96(6):696-702. PubMed ID: 23951827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression.
    Saggiorato E; Angusti T; Rosas R; Martinese M; Finessi M; Arecco F; Trevisiol E; Bergero N; Puligheddu B; Volante M; Podio V; Papotti M; Orlandi F
    J Nucl Med; 2009 Nov; 50(11):1785-93. PubMed ID: 19837765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Scintigraphy with 99mTc-MIBI in the diagnosis of axillary lymph node invasion of breast cancer].
    Mulero F; Nicolás F; Castellón MI; Claver MA; Abad L; Nuño de la Rosa JA
    Rev Esp Med Nucl; 2000 Oct; 19(6):416-22. PubMed ID: 11060271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99m MIBI parathyroid image findings.
    Sun SS; Shiau YC; Lin CC; Kao A; Lee CC
    Nucl Med Biol; 2001 Nov; 28(8):929-33. PubMed ID: 11711312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
    Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
    Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients.
    Takamura Y; Miyoshi Y; Taguchi T; Noguchi S
    Cancer; 2001 Jul; 92(2):232-9. PubMed ID: 11466674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma.
    Wang H; Chen XP; Qiu FZ
    World J Gastroenterol; 2004 May; 10(9):1281-5. PubMed ID: 15112342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
    Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
    J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical approach in patients with metastatic differentiated thyroid carcinoma and negative 131I whole body scintigraphy: importance of 99mTc MIBI scan combined with high resolution neck ultrasonography.
    Casara D; Rubello D; Saladini G; Mazzarotto R; Sotti G; Tomasella G; Pelizzo MR
    Tumori; 1999; 85(2):122-7. PubMed ID: 10363078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantified 99mTc-MIBI scintigraphy for predicting chemotherapy response in breast cancer patients: factors that influence the level of 99m Tc-MIBI uptake.
    Fuster D; Muñoz M; Pavia J; Palacín A; Bellet N; Mateos JJ; Martín F; Ortega M; Setoain FJ; Pons F
    Nucl Med Commun; 2002 Jan; 23(1):31-8. PubMed ID: 11748435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of 99mTc-MIBI image axillary lymph node in selecting operative method for breast cancer].
    Qu X; Wang Y; Chen D; Li C
    Zhonghua Wai Ke Za Zhi; 1999 Jan; 37(1):41-3. PubMed ID: 11829776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of 99mTc-MIBI and 99mTc-HMDP scintimammography for the diagnosis of breast cancer and its axillary metastases.
    Nishiyama Y; Yamamoto Y; Ono Y; Irie A; Yamauchi A; Satoh K; Ohkawa M
    Eur J Nucl Med; 2001 Apr; 28(4):522-8. PubMed ID: 11357504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
    Sergieva SB; Timcheva KV; Hadjiolov ND
    J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid cancer--comparison study with 131I and 201Tl].
    Nagamachi S; Jinnouchi S; Nishii R; Flores LG; Nakahara H; Futami S; Tamura S; Toshimori H; Kawai K
    Kaku Igaku; 2000 Mar; 37(2):89-98. PubMed ID: 10783567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging.
    Tatsumi M; Tsuruo T; Nishimura T
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):288-94. PubMed ID: 12002701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental and clinical observations of 99mTc-MIBI uptake correlate with P-glycoprotein expression in lung cancer.
    Yang A; Xue J; Li X; Yu Y; Deng H; Hu G; Meng X; Li J
    Nucl Med Commun; 2007 Sep; 28(9):696-703. PubMed ID: 17667748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m-sestamethoxyisobutylisonitrile scan as a predictor of chemotherapy response in malignant lymphomas compared with P-glycoprotein expression, multidrug resistance-related protein expression and other prognosis factors.
    Kao CH; Tsai SC; Wang JJ; Ho YJ; Ho ST; Changlai SP
    Br J Haematol; 2001 May; 113(2):369-74. PubMed ID: 11380401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
    Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
    J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.